EE Impact

Amgen

USA · Pharma & Healthcare

LeaveRussia detail: Scaling Back

Scaling back

Amgen is a biopharmaceutical company headquartered in Thousand Oaks, California. Amgen is the world's largest independent biotechnology firm.

Status last verified 03/08/2026Company website ↗LeaveRussia profile ↗

Business in Russia

The Thousand Oaks, California-based drugmaker opened an office in Moscow in 2006, and the company's activities currently cover the entire territory of the Russian Federation, from Kaliningrad to Kamchatka, according to its website.

Decision trail

Suspend all non-essential business activities; keep delivering some medicines

Local stats (LeaveRussia)

Assets(RF), mln.USD
95
Capital(RF), mln.USD
27
Glob.Revenue, mln.USD
25979
Revenue(RF), mln.USD
183
Staff(RF), 2021
149
Taxes(RF), mln.USD
8

Status history since 2022

  1. 03/08/2026 scaling back · Imported from KSE LeaveRussia

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.